Rybelsus (semaglutide), first oral GLP-1 treatment for type 2 diabetes
24 Settembre 2019
The U.S. Food and Drug Administration has approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes,
